Good morning to my US network! I am looking to speak with a Senior Computational Biologist/Immunologist Must have experience: - PhD in computational immunology/computational biology involving genomic and biologic analytics - Bioinformatics & statistical - NGS datasets (RNA) - R, Python & GIT - Pre-clinical & clinical trial - Pharma or Biotech To be based anywhere in the US (ideally East Coast) Pop me a message for more details! #ComputationalBiologist #ComputationalImmunologist #Senior #Biologist #Immunologist #genomics #genomic #ngs #rna #python #r #GIT #biotechnolgy
Leaman Life Sciences
Staffing and Recruiting
London, England 51,194 followers
Making hiring simple for the Pharmaceutical, Biotechnology and CRO industries.
About us
At Leaman Life Sciences, we are dedicated to streamlining the job search and recruitment process for both candidates and clients in the life sciences industry. Our team is comprised of experienced, highly trained, and professional talent acquisition personnel, who are committed to providing a personalized service with a focus on quality over quantity. We pride ourselves on our partnerships with leading pharmaceutical, biopharmaceutical, and CRO companies in the hiring of highly skilled life sciences professionals globally. Our philosophy of prioritizing the personal touch and simplifying complex talent acquisition processes sets us apart in an industry where stress and tension can be commonplace. If you are open to a confidential conversation, please reach out to the following person(s): E: info@leamanlifesciences.com T: +44(020) 3815 3490
- Website
-
http://www.leamanlifesciences.com/
External link for Leaman Life Sciences
- Industry
- Staffing and Recruiting
- Company size
- 11-50 employees
- Headquarters
- London, England
- Type
- Public Company
- Founded
- 2015
- Specialties
- Staffing and Recruiting, Clinical Development, Pharmaceutical, Biotechnology, CRO, Medical Device, Medical Affairs, Clinical Operations, Commercial and Marketing, Pharmacology, Regulatory Affairs, Contract Staffing, Permanent Staffing, Talent Acquisition, Market Access & HEOR, and Life Sciences
Locations
-
Primary
47 Marylebone Lane
London, England W1U 2NT, GB
-
37 WEST 57TH STREET FLOOR 5
MANHATTAN, New York 10019, US
Employees at Leaman Life Sciences
Updates
-
Hello Network, I am looking to speak with Research Associates to be based in Pittsburgh, Pennsylvania. (Relocation supported within the US if needed) *MUST HAVE EXPERIENCE* - Flow Cytometry - ELISA - Cell Culture - Experience within Pharma or Biotechnology company #research #researchassociate #scientist #flowcytometry #elisa #cellculture #mammaliancell #biology #immunology https://lnkd.in/eYCXbCGd
-
Boehringer Ingelheim inks $1.3B acquisition of Nerio Therapeutics and its preclinical checkpoint inhibitors! #leamanlifesciences https://lnkd.in/dXFZwBre
Boehringer inks $1.3B acquisition of Nerio and its preclinical checkpoint inhibitors
fiercebiotech.com
-
Roles in Germany
Good morning network, After 2 great weeks off holidaying in Spain I am back and looking to speak to people for the following positions! Regulatory: (all the be based in Munich) Regulatory Director (CMC authoring & strategy exp needed) Regulatory Director (Clinical authoring & strategy exp needed) Regulatory Writer (technical regulatory writing) Regulatory Project Manager Accounting position: (to be based in Hamburg) - Fluent German - 8+ years accounting experience - Experience with VAT Pop me a message if any of these roles are a fit for you! #germanyroles #germany #regulatory #regulatorywriting #accounting #vat
-
Ipsen announces partnership with Day One Biopharmaceuticals to bring tovorafenib to children living with pediatric low-grade glioma outside of the U.S. #leamanlifesciences https://lnkd.in/ewhmUbBM
Ipsen and Day One enter into exclusive ex-U.S. licensing agreement to commercialize tovorafenib for the most common childhood brain tumor
finance.yahoo.com
-
THIRD ARC BIO have successfully launched with an Oversubscribed $165 Million Series A Financing to Deliver Superior Biologics for Solid Tumors, Inflammatory & Immunology Diseases. They were launched in 2022 with seed financing from Omega Funds & have since advanced multiple programs that will enter the clinic starting in early 2025! Congratulations to Peter Lebowitz and Co ! #leamanlifesciences https://lnkd.in/eaJ-TAFK
Third Arc Bio Launches with Oversubscribed $165 Million Series A Financing to Deliver Superior Biologics for Solid Tumors and Inflammatory & Immunology (I&I) Diseases
prnewswire.com
-
Eli Lilly and Company to Acquire Morphic Therapeutic's to Improve Outcomes for Patients with Inflammatory Bowel Disease! #leamanlifesciences https://lnkd.in/dqjx6JTb
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease | Eli Lilly and Company
investor.lilly.com
-
Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development! #leamanlifesciences https://lnkd.in/eMt3TdmR
Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development
morningstar.com
-
Happy 4th July to all of our American friends, colleagues, clients, and family from everyone here at Leaman Life Sciences! #leamanlifesciences